S&P 500   4,297.14
DOW   33,912.44
QQQ   333.06
The Five Hottest Calls From The Q2 Earnings Season 
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
Buffett's firm buys more Apple, Amazon while betting on oil
Norway hits export record amid soaring gas prices
Stocks end higher on Wall Street; economic worries hit oil
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
Myanmar executions revive pressure for more sanctions
Stocks higher on Wall Street; economic worries hit oil price
New climate deal spurs hopes of more carbon storage projects
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
S&P 500   4,297.14
DOW   33,912.44
QQQ   333.06
The Five Hottest Calls From The Q2 Earnings Season 
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
Buffett's firm buys more Apple, Amazon while betting on oil
Norway hits export record amid soaring gas prices
Stocks end higher on Wall Street; economic worries hit oil
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
Myanmar executions revive pressure for more sanctions
Stocks higher on Wall Street; economic worries hit oil price
New climate deal spurs hopes of more carbon storage projects
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
S&P 500   4,297.14
DOW   33,912.44
QQQ   333.06
The Five Hottest Calls From The Q2 Earnings Season 
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
Buffett's firm buys more Apple, Amazon while betting on oil
Norway hits export record amid soaring gas prices
Stocks end higher on Wall Street; economic worries hit oil
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
Myanmar executions revive pressure for more sanctions
Stocks higher on Wall Street; economic worries hit oil price
New climate deal spurs hopes of more carbon storage projects
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
S&P 500   4,297.14
DOW   33,912.44
QQQ   333.06
The Five Hottest Calls From The Q2 Earnings Season 
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
Buffett's firm buys more Apple, Amazon while betting on oil
Norway hits export record amid soaring gas prices
Stocks end higher on Wall Street; economic worries hit oil
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
Myanmar executions revive pressure for more sanctions
Stocks higher on Wall Street; economic worries hit oil price
New climate deal spurs hopes of more carbon storage projects
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
NASDAQ:AERI

Aerie Pharmaceuticals - AERI Earnings Date, Estimates & Call Transcripts

$11.74
+0.17 (+1.47%)
(As of 08/15/2022 12:00 AM ET)
Add
Compare
Today's Range
$11.00
$11.80
50-Day Range
$5.68
$11.64
52-Week Range
$4.81
$17.21
Volume
574,850 shs
Average Volume
750,054 shs
Market Capitalization
$579.49 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$20.50

Earnings Summary

Upcoming
Earnings Date
Nov. 3Estimated
Actual EPS
(Aug. 4)
-$0.32 Beat By $0.20
Consensus EPS
(Aug. 4)
-$0.52
Last Year's Q3 EPS
(8/3/2021)
-$0.67
Skip Charts & View Estimated and Actual Earnings Data

AERI Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

AERI Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Aerie Pharmaceuticals Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20222($0.77)($0.61)($0.69) 
Q2 20221($0.74)($0.74)($0.74) 
Q3 20221($0.69)($0.69)($0.69) 
Q4 20221($0.60)($0.60)($0.60) 
FY 20225($2.80)($2.64) ($2.72)

AERI Earnings Date and Information

Aerie Pharmaceuticals last announced its earnings results on August 4th, 2022. The reported ($0.32) EPS for the quarter, topping analysts' consensus estimates of ($0.52) by $0.20. Aerie Pharmaceuticals has generated ($1.07) earnings per share over the last year (($1.07) diluted earnings per share). Earnings for Aerie Pharmaceuticals are expected to grow in the coming year, from ($1.97) to ($1.01) per share. Aerie Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 3rd, 2022 based off prior year's report dates.

Aerie Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
11/3/2022
(Estimated)
        
8/4/2022Q2($0.52)($0.32)+$0.20  
5/5/2022Q1 2022($0.65)($0.66)($0.01)($0.56)$30.19 million$29.84 million    
2/24/2022Q4 2021($0.68)$1.09+$1.77$1.22$30.82 million$114.67 million    
11/4/20219/30/2021($0.62)($0.72)($0.10)($0.58)$29.13 million$29.31 million  
8/3/20216/30/2021($0.65)($0.67)($0.02)($0.50)$26.43 million$27.19 million    
5/4/20213/31/2021($0.69)($0.72)($0.03)($0.53)$23.35 million$22.97 million  
2/25/202112/31/2020($0.75)($0.79)($0.04)($0.58)$21.75 million$24.68 million  
11/10/20209/30/2020($0.81)($0.65)+$0.16($0.44)$19.23 million$20.08 million  
8/6/20206/30/2020($0.79)($0.83)($0.04)($0.61)$18.65 million$18.03 million  
5/6/20203/31/2020($0.75)($0.83)($0.08)($0.61)$21.04 million$20.34 million  
2/20/2020Q4 2019($0.75)($0.96)($0.21)($0.71)$19.86 million$24.66 million
11/6/2019Q3($0.84)($0.86)($0.02)($0.63)$17.59 million$18.54 million  
8/7/2019Q2 2019($0.87)($0.80)+$0.07($0.56)$14.60 million$15.84 million
5/7/20193/31/2019($0.91)($0.78)+$0.13($0.50)$12.66 million$10.85 million
2/25/2019Q4 2018($1.06)($0.92)+$0.14($0.70)$12.11 million$14.46 million
11/6/2018Q3($1.33)($1.73)($0.40)($1.50)$5.63 million$7.30 million
8/8/2018Q2($0.98)($1.14)($0.16)($1.40)$1.16 million$2.42 million
5/8/2018Q1($0.87)($0.83)+$0.04($1.05)  
2/28/2018Q4 2017($1.2110)($1.38)($0.1690)($1.16)  
11/8/2017Q3 2017($0.89)($0.89)($0.89)
8/1/2017Q2 2017($0.84)($0.82)+$0.02($0.82)  
5/2/2017Q1 2017($0.74)($0.76)($0.02)($0.76)  
3/7/2017Q4 2016($0.67)($0.87)($0.20)($0.87)  
11/2/2016Q316($0.70)($0.67)+$0.03($0.81)
8/3/2016Q216($0.74)($0.72)+$0.02($0.87)
5/2/2016Q116($0.64)($0.72)($0.08)($0.85)
3/1/2016Q415($0.72)($0.64)+$0.08($0.76)
11/3/2015Q315($0.66)($0.69)($0.03)($0.69)
8/5/2015Q215($0.70)($0.73)($0.03)($0.73)
5/7/2015Q1 2015($0.62)($0.70)($0.08)($0.70)  
3/2/2015Q414($0.51)($0.69)($0.18)($0.69)
11/11/2014Q3 2014($0.40)($0.54)($0.14)($0.54)
8/6/2014Q2 2014($0.37)($0.49)($0.12)($0.49)
5/12/2014Q1 2014($0.35)($0.28)+$0.07($0.28)  
3/18/2014Q4 2013($0.21)($0.41)($0.20)($0.20)
12/4/2013Q3 2013($0.96)($5.78)($4.82)($0.75)  












Aerie Pharmaceuticals Earnings - Frequently Asked Questions

When is Aerie Pharmaceuticals's earnings date?

Aerie Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 3rd, 2022 based off last year's report dates. Learn more on AERI's earnings history.

Did Aerie Pharmaceuticals beat their earnings estimates last quarter?

In the previous quarter, Aerie Pharmaceuticals (NASDAQ:AERI) reported ($0.32) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.52) by $0.20. Learn more on analysts' earnings estimate vs. AERI's actual earnings.

How can I listen to Aerie Pharmaceuticals's earnings conference call?

The conference call for Aerie Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call

How much revenue does Aerie Pharmaceuticals generate each year?

Aerie Pharmaceuticals (NASDAQ:AERI) has a recorded annual revenue of $194.13 million.

How much profit does Aerie Pharmaceuticals generate each year?

Aerie Pharmaceuticals (NASDAQ:AERI) has a recorded net income of -$74.81 million. AERI has generated -$1.07 earnings per share over the last four quarters.

What is Aerie Pharmaceuticals's EPS forecast for next year?

Aerie Pharmaceuticals's earnings are expected to grow from ($1.97) per share to ($1.01) per share in the next year.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NASDAQ:AERI) was last updated on 8/16/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.